Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ShockWave Medical, Inc. SWAV
$298.72
-$3.91 (-1.31%)
На 18:01, 12 мая 2023
-20.19%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
10899522900.00000000
-
week52high
320.54
-
week52low
132.39
-
Revenue
489733000
-
P/E TTM
48
-
Beta
0.97882700
-
EPS
5.54000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Wells Fargo | Overweight | Overweight | 09 авг 2022 г. |
| Piper Sandler | Overweight | Overweight | 09 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 09 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 15 июл 2022 г. |
| Wells Fargo | Overweight | Overweight | 10 мая 2022 г. |
| Oppenheimer | Underperform | Perform | 06 сент 2022 г. |
| Piper Sandler | Overweight | Overweight | 29 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 окт 2022 г. |
| Wells Fargo | Overweight | Overweight | 08 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
| Wells Fargo | Equal-Weight | Overweight | 12 дек 2022 г. |
| Piper Sandler | Overweight | Overweight | 26 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Phung Trinh | D | 25740 | 941 | 03 февр 2023 г. |
| PUCKETT DAN | D | 43231 | 3221 | 02 февр 2023 г. |
| Phung Trinh | D | 26681 | 2000 | 02 февр 2023 г. |
| Godshall Douglas Evan | D | 154794 | 8486 | 02 февр 2023 г. |
| PUCKETT DAN | A | 46452 | 6514 | 01 февр 2023 г. |
| Phung Trinh | A | 28681 | 3529 | 01 февр 2023 г. |
| Zacharias Isaac | D | 72465 | 3721 | 01 февр 2023 г. |
| Zacharias Isaac | A | 76186 | 7165 | 01 февр 2023 г. |
| Godshall Douglas Evan | A | 163280 | 20354 | 01 февр 2023 г. |
| Zacharias Isaac | D | 69021 | 4000 | 26 янв 2023 г. |
Новостная лента
Ballooning Sales, Profit Send Shockwave Into An Early Breakout
Investors Business Daily
11 мая 2023 г. в 13:04
Shockwave Medical is Thursday's IBD Stock Of The Day as SWAV stock soars closer to a breakout on its big earnings beat and raise. The post Ballooning Sales, Profit Send Shockwave Into An Early Breakout appeared first on Investor's Business Daily.
Shockwave Medical surges ahead: impressive 1Q performance leads to raised revenue guidance for 2023
Proactive Investors
09 мая 2023 г. в 12:14
Shockwave Medical has upped its full-year 2023 guidance after its revenue beat across all of its product segments during its first quarter. The medical product company saw its revenue increase by 72% year-over-year to reach $161.1 million, ahead of consensus estimates of $147.3 million.
Shockwave Medical (SWAV) Q1 Earnings Top, Revenues Surge Y/Y
Zacks Investment Research
09 мая 2023 г. в 09:10
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.
Shockwave Medical, Inc. (SWAV) Q1 2023 Earnings Call Transcript
Seeking Alpha
08 мая 2023 г. в 21:57
Shockwave Medical, Inc. (NASDAQ:SWAV ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Debbie Kaster - Vice President, Investor Relations Doug Godshall - President and CEO Isaac Zacharias - President and CCO Trinh Phung - Vice President, Finance Conference Call Participants Adam Maeder - Piper Sandler Bill Plovanic - Canaccord Genuity Travis Steed - Bank of America Larry Biegelsen - Wells Fargo Michael Polark - Wolfe Research Cecilia Furlong - Morgan Stanley Imron Zafar - Deutsche Bank Mike Matson - Needham Operator Good afternoon. And welcome to Shockwave's First Quarter 2023 Earnings Conference Call.
Shockwave Medical (SWAV) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
08 мая 2023 г. в 19:02
Shockwave Medical (SWAV) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.39 per share a year ago.